Incidence, Risk Factors, Outcomes, and Risk Score Model of Acute Pancreatitis after Allogeneic Hematopoietic Stem Cell Transplantation
Copyright © 2019. Published by Elsevier Inc..
Acute pancreatitis (AP) has been recognized as an uncommon yet potentially lethal complication after hematopoietic stem cell transplant (HSCT). This retrospective, nested, case-control study reviewed data from 5284 consecutive patients who underwent allogeneic (allo)-HSCT between 2009 and 2018 at a single center, identifying 40 patients (0.76%) with AP after allo-HSCT. The diagnosis and severity of AP were established and classified according to existing criteria. Younger age (P = .008), grades II to IV acute graft-versus-host disease (P = .010), a history of donor lymphocyte infusion (P = .033), and pre-existing gallstones (P = .003) were independent risk factors of AP after allo-HSCT. Post-transplant AP had a trend to negatively influence overall survival (OS) and nonrelapse mortality (NRM) (P = .063) for allo-HSCT recipients, but no significant difference was found. Patients with moderately severe and severe AP had significantly lower OS (P = .002) and higher NRM (P = .000) than other patients. Based on these findings, a risk score model was also established to predict the occurrence of AP. Our risk score model performed well in terms of discrimination when applied to derivation samples. Patients were classified into a low-risk group (0 to 1 point), a medium-risk group (2 to 3 points), and a high-risk group (4 points or more). Significant difference was observed in AP incidence among the 3 groups. The predictive tool explored by our study might contribute to target high-risk patients and guide personalized AP prevention in allo-HSCT recipients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation - 26(2020), 6 vom: 19. Juni, Seite 1171-1178 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Xing-Lin [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acute pancreatitis |
---|
Anmerkungen: |
Date Completed 23.06.2021 Date Revised 23.06.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.bbmt.2019.12.721 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM304743828 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM304743828 | ||
003 | DE-627 | ||
005 | 20231225115635.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.bbmt.2019.12.721 |2 doi | |
028 | 5 | 2 | |a pubmed24n1015.xml |
035 | |a (DE-627)NLM304743828 | ||
035 | |a (NLM)31874219 | ||
035 | |a (PII)S1083-8791(19)31650-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Xing-Lin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Incidence, Risk Factors, Outcomes, and Risk Score Model of Acute Pancreatitis after Allogeneic Hematopoietic Stem Cell Transplantation |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.06.2021 | ||
500 | |a Date Revised 23.06.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2019. Published by Elsevier Inc. | ||
520 | |a Acute pancreatitis (AP) has been recognized as an uncommon yet potentially lethal complication after hematopoietic stem cell transplant (HSCT). This retrospective, nested, case-control study reviewed data from 5284 consecutive patients who underwent allogeneic (allo)-HSCT between 2009 and 2018 at a single center, identifying 40 patients (0.76%) with AP after allo-HSCT. The diagnosis and severity of AP were established and classified according to existing criteria. Younger age (P = .008), grades II to IV acute graft-versus-host disease (P = .010), a history of donor lymphocyte infusion (P = .033), and pre-existing gallstones (P = .003) were independent risk factors of AP after allo-HSCT. Post-transplant AP had a trend to negatively influence overall survival (OS) and nonrelapse mortality (NRM) (P = .063) for allo-HSCT recipients, but no significant difference was found. Patients with moderately severe and severe AP had significantly lower OS (P = .002) and higher NRM (P = .000) than other patients. Based on these findings, a risk score model was also established to predict the occurrence of AP. Our risk score model performed well in terms of discrimination when applied to derivation samples. Patients were classified into a low-risk group (0 to 1 point), a medium-risk group (2 to 3 points), and a high-risk group (4 points or more). Significant difference was observed in AP incidence among the 3 groups. The predictive tool explored by our study might contribute to target high-risk patients and guide personalized AP prevention in allo-HSCT recipients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Acute pancreatitis | |
650 | 4 | |a Allogeneic hematopoietic stem cell transplantation | |
650 | 4 | |a Risk prediction | |
700 | 1 | |a Han, Wei |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Peng |e verfasserin |4 aut | |
700 | 1 | |a Liu, Xiao |e verfasserin |4 aut | |
700 | 1 | |a Wang, Jing-Zhi |e verfasserin |4 aut | |
700 | 1 | |a Wang, Feng-Rong |e verfasserin |4 aut | |
700 | 1 | |a Yan, Chen-Hua |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Yuan-Yuan |e verfasserin |4 aut | |
700 | 1 | |a Mo, Xiao-Dong |e verfasserin |4 aut | |
700 | 1 | |a Wang, Yu |e verfasserin |4 aut | |
700 | 1 | |a Fu, Hai-Xia |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yu-Hong |e verfasserin |4 aut | |
700 | 1 | |a Chang, Ying-Jun |e verfasserin |4 aut | |
700 | 1 | |a Xu, Lan-Ping |e verfasserin |4 aut | |
700 | 1 | |a Liu, Kai-Yan |e verfasserin |4 aut | |
700 | 1 | |a Huang, Xiao-Jun |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Xiao-Hui |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation |d 1998 |g 26(2020), 6 vom: 19. Juni, Seite 1171-1178 |w (DE-627)NLM090383915 |x 1523-6536 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2020 |g number:6 |g day:19 |g month:06 |g pages:1171-1178 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bbmt.2019.12.721 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2020 |e 6 |b 19 |c 06 |h 1171-1178 |